A total of 227 patients with radioiodine-refractory DTC were assessed for eligibility in COSMIC-311. Patients were required to be 16 years of age or older with a confirmed diagnosis of DTC, measurable disease per RECIST v1.1, be previously treated with iodine-131, ...